Annika Jalava

657 total citations
13 papers, 582 citations indexed

About

Annika Jalava is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Annika Jalava has authored 13 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Neurology and 2 papers in Oncology. Recurrent topics in Annika Jalava's work include Neuroblastoma Research and Treatments (4 papers), Ubiquitin and proteasome pathways (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Annika Jalava is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Ubiquitin and proteasome pathways (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Annika Jalava collaborates with scholars based in Finland, United States and Switzerland. Annika Jalava's co-authors include Renu Kakar, Elizabeth A. Eklund, Jari Heikkilä, Karl E.O. Åkerman, Sabine Mai, Kent Eriksson, Sven Påhlman, Minnamaija Lintunen, M. Lintunen and Veijo Hukkanen and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Annika Jalava

13 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annika Jalava Finland 12 367 146 115 82 53 13 582
Patrick Amiguet Switzerland 10 239 0.7× 250 1.7× 41 0.4× 58 0.7× 23 0.4× 12 571
Clemens Hofmann Germany 10 392 1.1× 157 1.1× 190 1.7× 47 0.6× 28 0.5× 13 718
Maxim Poustovoitov United States 7 749 2.0× 103 0.7× 131 1.1× 55 0.7× 77 1.5× 9 941
Gina B. Scott United Kingdom 14 380 1.0× 159 1.1× 238 2.1× 73 0.9× 46 0.9× 27 684
Minako Nakazawa Japan 14 656 1.8× 102 0.7× 58 0.5× 192 2.3× 80 1.5× 23 911
Irja Johansson Sweden 9 299 0.8× 47 0.3× 56 0.5× 117 1.4× 96 1.8× 10 487
Sherri Lynn Hubbard Canada 11 289 0.8× 55 0.4× 107 0.9× 43 0.5× 78 1.5× 12 487
Piera Calamita Italy 12 340 0.9× 110 0.8× 48 0.4× 67 0.8× 48 0.9× 15 533
E. Takahashi Japan 16 436 1.2× 66 0.5× 80 0.7× 30 0.4× 81 1.5× 23 579
Maureen Mee United Kingdom 11 412 1.1× 100 0.7× 108 0.9× 64 0.8× 81 1.5× 14 678

Countries citing papers authored by Annika Jalava

Since Specialization
Citations

This map shows the geographic impact of Annika Jalava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Jalava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Jalava more than expected).

Fields of papers citing papers by Annika Jalava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Jalava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Jalava. The network helps show where Annika Jalava may publish in the future.

Co-authorship network of co-authors of Annika Jalava

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Jalava. A scholar is included among the top collaborators of Annika Jalava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Jalava. Annika Jalava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Eklund, Elizabeth A., Annika Jalava, & Renu Kakar. (2000). Tyrosine Phosphorylation of HoxA10 Decreases DNA Binding and Transcriptional Repression during Interferon γ-induced Differentiation of Myeloid Leukemia Cell Lines. Journal of Biological Chemistry. 275(26). 20117–20126. 78 indexed citations
2.
Eklund, Elizabeth A., Annika Jalava, & Renu Kakar. (1998). PU.1, Interferon Regulatory Factor 1, and Interferon Consensus Sequence-binding Protein Cooperate to Increase gp91 Expression. Journal of Biological Chemistry. 273(22). 13957–13965. 157 indexed citations
3.
Jalava, Annika, et al.. (1997). c-Myc Dependent Initiation of Genomic Instability During Neoplastic Transformation. Current topics in microbiology and immunology. 224. 201–207. 13 indexed citations
4.
Mai, Sabine & Annika Jalava. (1994). C-Myc binds to 5′ flanking sequence motifs of the dihydrofolate reductase gene in cellular extracts: role in proliferation. Nucleic Acids Research. 22(12). 2264–2273. 38 indexed citations
5.
Jalava, Annika & Sabine Mai. (1994). Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.. PubMed. 9(8). 2369–75. 23 indexed citations
6.
Heikkilä, Jari, Annika Jalava, & Kent Eriksson. (1993). The Selective Protein Kinase C Inhibitor GF 109203X Inhibits Phorbol Ester-Induced Morphological and Functional Differentiation of SH-SY5Y Human Neuroblastoma Cells. Biochemical and Biophysical Research Communications. 197(3). 1185–1193. 40 indexed citations
7.
Jalava, Annika, M. Lintunen, & Jari Heikkilä. (1993). Protein Kinase C-α But Not Protein Kinase C-ϵ Is Differentially Down-Regulated by Bryostatin 1 and Tetradecanoyl Phorbol 13-Acetate in SH-SY5Y Human Neuroblastoma Cells. Biochemical and Biophysical Research Communications. 191(2). 472–478. 28 indexed citations
8.
Jalava, Annika, Karl E.O. Åkerman, & Jari Heikkilä. (1993). Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH‐SY5Y human neuroblastoma cells through an α‐, β‐, and ζ‐protein kinase C‐independent pathway. Journal of Cellular Physiology. 155(2). 301–312. 51 indexed citations
9.
Jalava, Annika, Jari Heikkilä, Minnamaija Lintunen, Karl E.O. Åkerman, & Sven Påhlman. (1992). Staurosporine induces a neuronal phenotype in SH‐SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12‐O‐tetradecanoyl phorbol‐13 acetate TPA). FEBS Letters. 300(2). 114–118. 50 indexed citations
10.
Jalava, Annika, et al.. (1990). Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.. PubMed. 50(11). 3422–8. 18 indexed citations
11.
Jalava, Annika, Jari Heikkilä, & Karl E.O. Åkerman. (1988). Decline in c-myc mRNA expression but not the induction of c-fos mRNA expression is associated with differentiation of SH-SY5Y human neuroblastoma cells. Experimental Cell Research. 179(1). 10–17. 38 indexed citations
12.
Hyypiä, Timo, Annika Jalava, Steven H. Larsen, Perttu Terho, & Veijo Hukkanen. (1985). Detection of Chlamydia trachomatis in Clinical Specimens by Nucleic Acid. Microbiology. 131(4). 975–978. 37 indexed citations
13.
Ziegler, Thedi, Veijo Hukkanen, Pertti Arstila, et al.. (1985). Typing of herpes simplex virus isolates with monoclonal antibodies and by nucleic acid spot hybridization. Journal of Virological Methods. 12(1-2). 169–177. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026